NASDAQ | TSX: ACB
Sourdough Shortcuts are now infused with live
resin THCA diamonds, adding a super high potency offering to
Aurora's portfolio of medical products
EDMONTON, AB, Aug. 1, 2023 /PRNewswire/ - Aurora Cannabis
(NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to
cannabis, has launched its first high-potency infused pre-roll for
medical cannabis patients, with more than 50% total THC. Sourdough
Shortcuts, launched under the San Rafael '71 brand, are infused
with pure live resin THCA diamonds, delivering 50-56% THC, and
giving patients a shortcut to get the benefits they rely on from
their medical cannabis. The first lot to hit the Aurora Medical
channel were tested at 52.8% total THC.
Available in a three-pack of individual 0.35g pre-rolls,
Sourdough Shortcuts contain a proprietary blend of live resin and
whole milled flower from one of Aurora's most popular original
cultivars, Sourdough. Developed from a cross of Cake and Sour
Diesel strains, Sourdough is known for its distinct aroma of sour
mixed with baked goods.
"We continue to innovate our portfolio to meet evolving patient
needs and are committed to delivering the novel, high-quality
products we know our patients are looking for," says
Lana Culley, VP of Science & Innovation at Aurora
Cannabis. "Sourdough Shortcuts are designed with patients in mind
and provide a new level of potency in both a convenient format and
elevated product experience."
Sourdough Shortcuts are now available to patients on the Aurora
Medical website.
About Aurora:
Aurora is opening the world to cannabis, serving both the
medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as well
as CBD brands, Reliva and KG7. Medical cannabis brands include
MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as
well as international brands, Pedanios, Bidiol and CraftPlant.
Aurora also has a controlling interest in Bevo Farms Ltd.,
North America's leading supplier
of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, performance, wellness and adult recreational markets
wherever they are launched. Learn more at www.auroramj.com and
follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward-looking
Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements with respect to
the launch of new products to market and the Company's continued
commitment to product innovation.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in developing
forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from
market research and industry analysis and on assumptions based on
data and knowledge of this industry which the Company believes to
be reasonable. Forward-looking statements are subject to a variety
of risks, uncertainties and other factors that management believes
to be relevant and reasonable in the circumstances could cause
actual events, results, level of activity, performance, prospects,
opportunities or achievements to differ materially from those
projected in the forward-looking statements. These risks include,
but are not limited to, the ability to retain key personnel, the
ability to continue investing in infrastructure to support growth,
the ability to obtain financing on acceptable terms, the continued
quality of our products, customer experience and retention, the
development of third party government and non-government consumer
sales channels, management's estimates of consumer demand in
Canada and in jurisdictions where
the Company exports, expectations of future results and expenses,
the risk of successful integration of acquired business and
operations, management's estimation that SG&A will grow
only in proportion of revenue growth, the ability to expand and
maintain distribution capabilities, the impact of competition, the
general impact of financial market conditions, the yield from
cannabis growing operations, product demand, changes in prices of
required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics,
pandemics or other public health crises, including the current
outbreak of COVID-19, and other risks, uncertainties and
factors set out under the heading "Risk Factors" in the Company's
annual information form dated September 20,
2022 (the "AIF") and filed with Canadian securities
regulators available on the Company's issuer profile on SEDAR
at www.sedar.com and filed with and available on the
SEC's website at www.sec.gov. The Company cautions that the
list of risks, uncertainties and other factors described in
the AIF is not exhaustive and other factors could also
adversely affect its results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in evaluating the
forward-looking statements and are cautioned not to place undue
reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-launches-innovative-infused-pre-rolls-with-50-thc-for-medical-cannabis-patients-on-auroramedicalcom-301889997.html
SOURCE Aurora Cannabis Inc.